Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Abstract
Inflammation is a fundamental innate immune response to perturbed tissue homeostasis. Chronic inflammatory processes affect all stages of tumour development as well as therapy. In this Review, we outline the principal cellular and molecular pathways that coordinate the tumour-promoting and tumour-antagonizing effects of inflammation and we discuss the crosstalk between cancer development and inflammatory processes. In addition, we discuss the recently suggested role of commensal microorganisms in inflammation-induced cancer and we propose that understanding this microbial influence will be crucial for targeted therapy in modern cancer treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while the intestinal microbiota can promote local inflammation and development of gastrointestinal cancers (Elinav et al., 2013; Garrett, 2015), it can exert an opposing effect on transplanted tumors at distal sites by priming the host immune system and enhancing the systemic anti-tumor immune response (Dzutsev et al., 2017).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Elinav et al., 2013
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Cited by
Items 201–300 of 1,001
The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity
Lü, D., Liu, L., Sun, Y., Song, J., Yin, Q., Zhang, G., Fang, Q., Hu, Z., Yang, Z., Zhou, Z. C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-019-0577-9 · Cited by 123
Cancer whole-genome sequencing: present and future
Nakagawa, H., Wardell, C. P., Furuta, M., Taniguchi, H., & Fujimoto, A. (2015) · Oncogene · doi:10.1038/onc.2015.90 · Cited by 123
Jia, W., Wu, J., Jia, H., Yang, Y., Zhang, X., Chen, K., & Su, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143061 · Cited by 121
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Uehara, I., & Tanaka, N. (2018) · Cancers · doi:10.3390/cancers10070219 · Cited by 115
Liao, K., Zhang, X., Liu, J., Teng, F., He, Y., Cheng, J., Yang, Q., Zhang, W., Xie, Y., Guo, D., et al. (2023) · MedComm · doi:10.1002/mco2.350 · Cited by 121
Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth
Satpathy, S. R., Jala, V. R., Bodduluri, S. R., Krishnan, E., Hegde, B., Hoyle, G. W., Fraig, M., Luster, A. D., & Haribabu, B. (2015) · Nature Communications · doi:10.1038/ncomms8064 · Cited by 120
Wu, M., Guo, J., Guo, L., & Zuo, Q. (2016) · Tumor Biology · doi:10.1007/s13277-016-5122-y · Cited by 119
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma
Chen, M., Lu, M., Hsieh, C., & Chen, W. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00573-x · Cited by 119
Mocellin, M. C., Camargo, C. D. Q., Nunes, E. A., Fiates, G. M. R., & Trindade, E. B. S. D. M. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.04.013 · Cited by 119
The immune system in the normal endometrium and implications for endometrial cancer development
Vanderstraeten, A., Tuyaerts, S., & Amant, F. C. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.12.006 · Cited by 117
Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
Rajagopal, C., Lankadasari, M. B., Aranjani, J. M., & Harikumar, K. B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.034 · Cited by 117
Takagi, K., Buettner, S., & IJzermans, J. N. M. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.04.046 · Cited by 116
Guo, W., Cai, S., Zhang, F., Shao, F., Zhang, G., Zhou, Y., Zhao, L., Tan, F., Gao, S., & He, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12995 · Cited by 115
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real?
Thomas, R. M., & Jobin, C. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.005 · Cited by 110
Nanomedicine Strategies to Target Tumor-Associated Macrophages
Binnemars-Postma, K., Storm, G., & Prakash, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050979 · Cited by 108
Xu, Q., Yan, Y., Gu, S., Mao, K., Zhang, J., Huang, P., Zhou, Z., Chen, Z., Zheng, S., Liang, J., et al. (2018) · Journal of Immunology Research · doi:10.1155/2018/4925498 · Cited by 114
The Dynamic Changes of Gut Microbiota in Muc2 Deficient Mice
Wu, M., Wu, Y., Li, J., Bao, Y., Guo, Y., & Yang, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092809 · Cited by 116
Jiang, T., Bai, Y., Zhou, F., Li, W., Gao, G., Su, C., Ren, S., Chen, X., & Zhou, C. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.02.009 · Cited by 103
Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
Wang, D., Bai, N., Hu, X., Ouyang, X., Yao, L., Tao, Y., & Wang, Z. (2019) · PeerJ · doi:10.7717/peerj.7132 · Cited by 114
A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk
Zeleznik, O. A., Eliassen, A. H., Kraft, P. L., Poole, E. M., ROSNER, B. A., Jeanfavre, S., Deik, A., Bullock, K. H., Hitchcock, D. S., Ávila-Pacheco, J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2567 · Cited by 116
The changing role of natural killer cells in cancer metastasis
Chan, I. S., & Ewald, A. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci143762 · Cited by 114
Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
Zhou, S., & Chen, X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s86396 · Cited by 113
Hsu, D. C., & Sereti, I. (2016) · Drugs · doi:10.1007/s40265-016-0546-7 · Cited by 112
Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis
Li, D., Yuan, X., Liu, J., Li, C., & Li, W. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.08.51 · Cited by 112
Abu-Remaileh, M., Bender, S., Raddatz, G., Ansari, I., Cohen, D., Gutekunst, J., Musch, T., Linhart, H., Breiling, A., Pikarsky, E., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3295 · Cited by 101
Wang, R., Luo, Y., Lu, Y., Wang, D., Wang, T., Pu, W., & Wang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4703253 · Cited by 109
Immunological Consequences of Epithelial–Mesenchymal Transition in Tumor Progression
Chockley, P. J., & Keshamouni, V. G. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600458 · Cited by 94
Hsu, D. C., Ma, Y. F., Hur, S., Li, D., Rupert, A. W., Scherzer, R., Kalapus, S. C., Deeks, S. G., Sereti, I., & Hsue, P. Y. (2016) · AIDS · doi:10.1097/qad.0000000000001149 · Cited by 107
Photoaging and skin cancer: Is the inflammasome the missing link?
Awad, F., Assrawi, E., Louvrier, C., Jumeau, C., Giurgea, I., Amselem, S., & Karabina, S.-A. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.003 · Cited by 98
Tumor-associated macrophages: a short compendium
Prenen, H., & Mazzone, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2997-3 · Cited by 108
Targeting Lipid Peroxidation for Cancer Treatment
Clemente, S. M., Martínez-Costa, Ó. H., Monsalve, M., & Samhan-Arias, A. K. (2020) · Molecules · doi:10.3390/molecules25215144 · Cited by 106
Liu, R., Yuan, W., Zeng, Q., Chan, K., Xiao, C., Zhao, X., Chen, M., Ouyang, F., Chen, D., Zheng, L., et al. (2015) · Hepatology · doi:10.1002/hep.28020 · Cited by 106
Shi, H., Zhang, J., Han, X., Li, H., Xie, M., Sun, Y., Liu, W., Ba, X., & Zeng, X. (2016) · International Journal of Cancer · doi:10.1002/ijc.30538 · Cited by 106
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 106
Lin, R., Piao, M., Song, Y., & Liu, C. (2020) · Journal of Immunology Research · doi:10.1155/2020/9242601 · Cited by 105
Zhang, G., Gao, Z.-X., Guo, X., Ma, R., Wang, X., Zhou, P., Li, C., Tang, Z., Zhao, R., & Gao, P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166224 · Cited by 105
Periodontal Disease and Breast Cancer: Prospective Cohort Study of Postmenopausal Women
Freudenheim, J. L., Genco, R. J., LaMonte, M. J., Millen, A. E., Hovey, K. M., Mai, X., Nwizu, N., Andrews, C. A., & Wactawski-Wende, J. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0750 · Cited by 95
Chen, Z., Wang, K., Lü, H., Xue, D., Fan, M., Zhuang, Q., Yin, S., He, X., & Xu, R. (2019) · Cancer Management and Research · doi:10.2147/cmar.s186976 · Cited by 105
Subramaniam, K. S., Omar, I. S., Kwong, S. C., Mohamed, Z., Woo, Y. L., Adenan, N. A. M., & Chung, I. (2016) · Oxford University Research Archive (ORA) (University of Oxford) · Cited by 106
Wu, Y., Wu, X., Wu, L., Wang, X., & Liu, Z. (2017) · Translational research · doi:10.1016/j.trsl.2017.08.004 · Cited by 104
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms
Bjørn, M. E., & Hasselbalch, H. C. (2015) · Mediators of Inflammation · doi:10.1155/2015/648090 · Cited by 103
Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer
Ma, H., Liu, X.-Z., & Liang, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i29.6619 · Cited by 103
Chen, L., Yan, Y., Zhu, L., Cong, X., Li, S., Song, S., Song, H., & Xue, Y. (2017) · Cancer Management and Research · doi:10.2147/cmar.s151026 · Cited by 104
Ablation of sensory nerves favours melanoma progression
Prazeres, P. H. D. M., Leonel, C., da Silva, W. N., Rocha, B. G. S., Santos, G. S. P., Costa, A. C., Picoli, C. C., Sena, I. F. G., Gonçalves, W. A., Vieira, M. S., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15381 · Cited by 103
Leukaemia 'firsts' in cancer research and treatment
Greaves, M. F. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.3 · Cited by 102
Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
Xu, L., Yu, S., Zhuang, L., Wang, P., Shen, Y., Lin, J., & Meng, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.16865 · Cited by 102
Association of circulating inflammation proteins and gallstone disease
Liu, Z., Kemp, T. J., Gao, Y., Corbel, A., McGee, E. E., Wang, B., Shen, M.-C., Rashid, A., Hsing, A. W., Hildesheim, A., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14265 · Cited by 102
Dong, M., Shi, Y., Yang, J., Zhou, Q., Lian, Y., Wang, D., Ma, T., Zhang, Y., Mi, Y., Gu, X., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920937425 · Cited by 102
Wu, D., Yin, Z., Ji, Y., Li, L., Li, Y., Meng, F., Ren, X., & Xu, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-87540-0 · Cited by 102
Host-Microbiome Interaction in Lung Cancer
Dong, Q., Chen, E. S., Zhao, C. N., & Jin, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679829 · Cited by 102
Self-citationCancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 90
Fanok, M. H., Sun, A. L., Fogli, L. K., Narendran, V., Eckstein, M., Kannan, K. S., Dolgalev, I., Lazaris, C., Heguy, A., Laird, M. E., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.028 · Cited by 102
The microbiome and lung cancer
Maddi, A., Sabharwal, A., Violante, T., Manuballa, S., Genco, R. J., Patnaik, S. K., & Yendamuri, S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.88 · Cited by 101
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
Lopetuso, L. R., Severgnini, M., Pecere, S., Ponziani, F. R., Boškoski, I., Larghi, A., Quaranta, G., Masucci, L., Ianiro, G., Camboni, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231789 · Cited by 102
Immune cells as tumor drug delivery vehicles
Combes, F., Meyer, E., & Sanders, N. N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.043 · Cited by 102
Tackling TAMs for Cancer Immunotherapy: It’s Nano Time
Yang, Y., Guo, J., & Huang, L. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.003 · Cited by 98
Mijnheer, G., Lutter, L., Mokrý, M., van der Wal, M., Scholman, R. C., Fleskens, V., Pandit, A., Tao, W., Wekking, M., Vervoort, S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22975-7 · Cited by 101
Oshima, H., Nakayama, M., Han, T.-S., Naoi, K., Ju, X., Maeda, Y., Robine, S., Tsuchiya, K., Sato, T., Sato, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2036 · Cited by 91
Jiang, T., Qiao, M., Zhao, C., Li, X., Gao, G., Su, C., Ren, S., & Zhou, C. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2126-z · Cited by 100
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 99
D’Uva, G., Baci, D., Albini, A., & Noonan, D. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.10.013 · Cited by 98
Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
Tao, C., Huang, K., Shi, J., Hu, Q., Li, K., & Zhu, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00183 · Cited by 98
Li, Y., Zhang, Z., Hu, Y., Yan, X., Song, Q., Wang, G., Chen, R., Jiao, S., & Wang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00654 · Cited by 98
Lung microbiome alterations in NSCLC patients
Zheng, L., Sun, R., Zhu, Y., Li, Z., She, X., Jian, X., Yu, F., Deng, X., Sai, B., Wang, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91195-2 · Cited by 99
Mousavi, S. E., Delgado-Saborit, J. M., Adivi, A., Pauwels, S., & Godderis, L. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151654 · Cited by 98
De novo analysis of bulk RNA-seq data at spatially resolved single-cell resolution
Liao, J., Qian, J., Yin, F., Chen, Z., Zhuang, X., Zhang, N., Shao, X., Hu, Y., Yang, P., Cheng, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34271-z · Cited by 98
Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy
Yu, Z.-W., Zheng, M. H., Fan, H., Liang, X., & Tang, Y. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00209-8 · Cited by 97
Millar, S., Navarro, P., Harrington, J. M., Perry, I. J., & Phillips, C. M. (2021) · Nutrients · doi:10.3390/nu13010222 · Cited by 96
van den Heuvel, T. R. A., Wintjens, D., Jeuring, S. F. G., Wassink, M. H. H., Romberg-Camps, M. J. L., Oostenbrug, L. E., Sanduleanu, S., Hameeteman, W. M., Zeegers, M. P., Masclee, A., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30183 · Cited by 96
Zhang, H., Xu, Z.-S., Lin, H. I., Li, M., Xia, T., Cui, K., Wang, S., Li, Y., Shu, H., & Wang, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-05796-z · Cited by 95
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
Afshari, A. R., Sanati, M., Mollazadeh, H., Kesharwani, P., Johnston, T. P., & Sahebkar, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.008 · Cited by 95
Piao, H., Fu, L., Wang, Y., Liu, Y., Wang, Y., Meng, X., Yang, D., Xiao, X., & Zhang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02366-6 · Cited by 96
The role of dendritic cells in cancer
Hansen, M., & Andersen, M. H. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0592-y · Cited by 96
Tsilimigras, D. I., Moris, D., Mehta, R., Paredes, A. Z., Sahara, K., Guglielmi, A., Aldrighetti, L. A., Weiss, M. J., Bauer, T. W., Alexandrescu, S. T., et al. (2020) · HPB · doi:10.1016/j.hpb.2020.03.011 · Cited by 95
Li, J., Liu, C., Chen, Y., Gao, C., Wang, M., Ma, X., Zhang, W., Zhuang, J., Yao, Y., & Sun, C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01119 · Cited by 93
Macrophages in tumor: An inflammatory perspective
Goswami, K. K., Bose, A., & Baral, R. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108875 · Cited by 94
Tsuruta, A., Shiiba, Y., Matsunaga, N., Fujimoto, M., Yoshida, Y., Koyanagi, S., & Ohdo, S. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0786 · Cited by 93
Toll‐like receptors in health and disease
Wang, K., Huang, H., Qi, Z., Ding, H., & Li, Y. (2024) · MedComm · doi:10.1002/mco2.549 · Cited by 93
A day in the life of the meta-organism: diurnal rhythms of the intestinal microbiome and its host
Thaiss, C. A., Zeevi, D., Levy, M., Segal, E., & Elinav, E. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1016690 · Cited by 89
Self-citationInflammasome: Cancer's friend or foe?
Terlizzi, M., Casolaro, V., Pinto, A., & Sorrentino, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.002 · Cited by 97
Integrated Akt/PKB Signaling in Immunomodulation and Its Potential Role in Cancer Immunotherapy
Xue, G., Zippelius, A., WICKI, A. N., Mandalà, M., Tang, F., Massi, D., & Hemmings, B. A. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv171 · Cited by 92
Orditura, M., Galizia, G., Diana, A., Saccone, C., Cobellis, L., Ventriglia, J., Iovino, F., Romano, C. P., Morgillo, F., Mosca, L., et al. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000038 · Cited by 92
Dewald, J., Colomb, F., Bobowski-Gerard, M., Groux-Degroote, S., & Delannoy, P. (2016) · Cells · doi:10.3390/cells5040043 · Cited by 84
Chen, L., Brar, M. S., Leung, F. C.-C., & Hsiao, W. L. W. (2016) · Oncotarget · doi:10.18632/oncotarget.8886 · Cited by 91
Ambade, A., Satishchandran, A., & Szabo, G. (2016) · Scientific Reports · doi:10.1038/srep21340 · Cited by 85
Interplay between inflammatory tumor microenvironment and cancer stem cells (Review)
Zhang, S., Yang, X., Wang, L., & Zhang, C. (2018) · Oncology Letters · doi:10.3892/ol.2018.8716 · Cited by 91
Zhang, Y., Jiang, X., Zhang, N., Chen, M., Wang, H., & Zhu, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.017 · Cited by 91
Zheng, S., Shi, J., Fu, X., Wang, C., Sun, X., Chen, C., Zhuang, Y., Zou, X., Li, Y., & Zhang, H. (2020) · Nanoscale · doi:10.1039/c9nr10622g · Cited by 91
Perillo, F., Amoroso, C., Strati, F., Giuffrè, M. R., Díaz‐Basabe, A., Lattanzi, G., & Facciotti, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155389 · Cited by 91
Zeng, J., Zhang, G., Chen, C., Li, K., Wen, Y., Zhao, J., & Wu, P. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.555508 · Cited by 91
Regulation of C-X-C chemokine gene expression by keratin 17 and hnRNP K in skin tumor keratinocytes
Chung, B. M., Arutyunov, A., Ilagan, E., Yao, N., Wills-Karp, M. A., & Coulombe, P. A. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201408026 · Cited by 91
Exploring the Crosstalk between Inflammation and Epithelial‐Mesenchymal Transition in Cancer
Chattopadhyay, I., Ambati, R. R., & Gundamaraju, R. (2021) · Mediators of Inflammation · doi:10.1155/2021/9918379 · Cited by 90
Inflammatory Cytokine: An Attractive Target for Cancer Treatment
Lee, H., Lee, H.-J., & Chang, J. (2022) · Biomedicines · doi:10.3390/biomedicines10092116 · Cited by 90
Gao, Y., Guo, W., Cai, S., Zhang, F., Shao, F., Zhang, G., Liu, T., Tan, F., Li, N., Xue, Q., et al. (2019) · Journal of Cancer · doi:10.7150/jca.30281 · Cited by 90
Liu, J., Dai, Y., Zhou, F., Long, Z., Li, Y., Liu, B., Xie, D., Tang, J. H., Tan, J., Yao, K., et al. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.05.024 · Cited by 89
Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
Orciani, M., Caffarini, M., Biagini, A., Lucarini, G., Carpini, G. D., Berretta, A., Primio, R. D., & Ciavattini, A. (2018) · Stem Cells International · doi:10.1155/2018/1716246 · Cited by 89
Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
Nasrollahzadeh, E., Razi, S., Keshavarz‐Fathi, M., Mazzone, M., & Rezaei, N. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02616-6 · Cited by 89
Song, M., Nishihara, R., Cao, Y., Chun, E., Qian, Z. R., Mima, K., Inamura, K., Masugi, Y., Nowak, J. A., Nosho, K., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0605 · Cited by 89
Rhost, S., Hughes, É., Harrison, H., Rafnsdóttir, S., Jacobsson, H., Gregersson, P., Magnusson, Y., Fitzpatrick, P., Andersson, D., Berger, K., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1060-5 · Cited by 88
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
Patra, M. C., Shah, M., & Choi, S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.002 · Cited by 88
Metadata
- Authors
- Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A.
- Affiliations
- Weizmann Institute of Science (IL)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Elinav, Eran
- Flavell, Richard A.
- Venue
- Nature reviews. Cancer
- Published
- 2013-10-24
- Volume
- 13
- Issue
- 11
- Pages
- 759-771
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2143841612
- Cited by
- 2,000
- References
- 154
- Citations by year
- 2026: 83 · 2025: 150 · 2024: 223 · 2023: 167 · 2022: 204 · 2021: 187 · 2020: 202 · 2019: 132 · 2018: 144 · 2017: 149 · 2016: 142 · 2015: 124 · 2014: 90 · 2013: 2
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- inflammation-associated tumorigenesis, chronic inflammation, tumor progression, tumor microenvironment, gut microbiota, commensal microorganisms, innate immunity, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Homeostasis, Humans, Immunity, Innate, Inflammation, Neoplasm Metastasis, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Cell Proliferation, Mice, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.